MedTrace Logo

Extensive Prospective Validation Study of the NightOwl Home Sleep Apnea Test

NCT03635918 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2018-08-17

No results posted yet for this study

Summary

Extensive Prospective validation study of the NightOwl, a Type IV home sleep apnea test (HSAT), compared to traditional PSG and HSAT monitors.

Conditions

Interventions

DEVICE

NightOwl HSAT

Patient wears the NightOwl sensor device

Sponsors & Collaborators

  • Ziekenhuis Oost-Limburg

    collaborator OTHER

  • Ectosense NV

    lead INDUSTRY

Principal Investigators

  • Frederik Massie, ir. · Ectosense NV

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-08-15
Primary Completion
2019-09-15
Completion
2019-09-15

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03635918 on ClinicalTrials.gov